Hypervalent Iodine Mediated Synthesis of Thiosulfonates from Sulfonyl Hydrazides and Their Transformation into Symmetrical Disulfides
Synthesis · 18.06.2024 · 56 (12) · 1923-1931
DOI: 10.1055/a-2260-0346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 18.06.2024. Verfasst von Virendra Prasad und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Science and Engineering Research Board, Banaras Hindu University.
Abstract (Originalsprache)
A transition-metal-free synthesis of thiosulfonates has been accomplished by the disproportionate coupling of readily available and inexpensive sulfonyl hydrazides embracing hypervalent iodine(III) [phenyliodine(III) diacetate (PIDA)] as an oxidant. This synthesis involves cleavage of the S–N bond and is endowed with creation of a new S–S bond. The thiosulfonates were further reduced with CS2/KOH to obtain symmetrical disulfides. This protocol features mild reaction conditions in open air, an inexpensive oxidant, and high functional group tolerance with good to excellent product yields.
Förderung
- Science and Engineering Research Board
- Banaras Hindu University
Zitieren
APA
Prasad, V., Yadav, A., & Kumar, R. (2024). Hypervalent Iodine Mediated Synthesis of Thiosulfonates from Sulfonyl Hydrazides and Their Transformation into Symmetrical Disulfides. Synthesis, 56(12), 1923-1931. https://doi.org/10.1055/a-2260-0346
Vancouver
Prasad V, Yadav A, Kumar R. Hypervalent Iodine Mediated Synthesis of Thiosulfonates from Sulfonyl Hydrazides and Their Transformation into Symmetrical Disulfides. Synthesis. 2024;56(12):1923-1931. doi:10.1055/a-2260-0346
BibTeX
@article{Prasad2024,
author = {Prasad, Virendra and Yadav, Ashvani and Kumar, Rohit},
title = {Hypervalent Iodine Mediated Synthesis of Thiosulfonates from Sulfonyl Hydrazides and Their Transformation into Symmetrical Disulfides},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {12},
pages = {1923--1931},
doi = {10.1055/a-2260-0346}
}
EUVIMED